Rapid effector function of varicella-zoster virus glycoprotein I-specific CD4+ T cells many decades after primary infection

J Infect Dis. 2007 Mar 1;195(5):660-4. doi: 10.1086/511274. Epub 2007 Jan 22.

Abstract

Glycoprotein I (gI) of varicella-zoster virus (VZV) contributes to viral virulence and is therefore a potentially important target for T cell control of viral replication. Persisting effector function of gI-specific T cells after primary infection has not been previously examined. We have shown that, many decades after infection, relatively high frequencies gI-specific interferon- gamma responses are detectable ex vivo and are dominated by CD4(+) T cells. We characterized the optimal peptide of the strongest response in our cohort showing restriction through DRB4*01. These findings are consistent with gI-specific CD4(+) T cell involvement in the control of VZV replication.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • CD4-Positive T-Lymphocytes / drug effects*
  • CD4-Positive T-Lymphocytes / metabolism*
  • CD8-Positive T-Lymphocytes / metabolism
  • Cells, Cultured
  • Chickenpox / immunology*
  • Herpesvirus 3, Human / immunology*
  • Herpesvirus 3, Human / metabolism
  • Humans
  • Interferon-gamma / metabolism
  • Leukocytes, Mononuclear / metabolism
  • Viral Envelope Proteins / metabolism
  • Viral Envelope Proteins / pharmacology*

Substances

  • Viral Envelope Proteins
  • glycoprotein E, varicella-zoster virus
  • Interferon-gamma